NCT02670889: Urease Inhibitor Drug Treatment for Urea Cycle Disorders |
|
|
| Not yet recruiting | 1/2 | 16 | US | Acetohydroxamic Acid, Lithostat, AHA, Isotopic Intravenous [13C]-Urea | Nicholas Ah Mew, Data Management and Coordinating Center (DMCC), Children's Hospital of Philadelphia | Ornithine Transcarbamylase Deficiency, Argininosuccinate Synthetase Deficiency (Citrullinemia), Argininosuccinic Acid Lyase Deficiency (Argininosuccinic Aciduria), Carbamyl-Phosphate Synthase I Deficiency | 03/18 | 03/19 | | |